ETHYLICUM
Pancreatic Cyst
Milton S. Hershey Medical CenterSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Pancreatic Cyst cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TAMOXIFEN University of Nebraska | Phase 1 | CC |
Pyruvate M.D. Anderson Cancer Center | Phase 1 | CC |
Same molecule, other indications
ETHYLICUM is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →